This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07199/identifier/chemspider/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB07199/identifier/pdb/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07199/identifier/pubchem-compound/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n11http://linked.opendata.cz/resource/drugbank/drug/DB07199/identifier/pubchem-substance/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07199/identifier/drugbank/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07199
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB07199 n13:DB07199
dcterms:title
(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID
adms:identifier
n7:13122494 n10:15991559 n11:99443670 n12:DB07199 n14:698
n3:IUPAC-Name
n4:271B53BC-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B53C2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B53C1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B53BE-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B53BF-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B53C0-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B53BA-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B53BB-363D-11E5-9242-09173F13E4C5 n4:271B53B8-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B53B9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B53C8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B53C9-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B53C3-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B53C4-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B53C6-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B53C5-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B53C7-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B53CE-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B53D0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B53D1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B53CD-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B53CC-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B53CF-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B53BD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B53CA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B53CB-363D-11E5-9242-09173F13E4C5